Success Metrics

Clinical Success Rate
85.7%

Based on 12 completed trials

Completion Rate
86%(12/14)
Active Trials
5(24%)
Results Posted
8%(1 trials)
Terminated
2(10%)

Phase Distribution

Ph phase_4
1
5%
Ph not_applicable
18
86%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution19 total trials
Phase 4Post-market surveillance
1(5.3%)
N/ANon-phased studies
18(94.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

12 of 15 finished

Non-Completion Rate

20.0%

3 ended early

Currently Active

5

trials recruiting

Total Trials

21

all time

Status Distribution
Active(5)
Completed(12)
Terminated(3)
Other(1)

Detailed Status

Completed12
Recruiting4
Terminated2
Active, not recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
5
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (5.3%)
N/A18 (94.7%)

Trials by Status

completed1257%
recruiting419%
active_not_recruiting15%
unknown15%
terminated210%
withdrawn15%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT06314477Not Applicable

Effect of CPAP Treatment in Patients With Severe Uncontrolled Asthma: The ASTHMA-SLEEP Trial

Recruiting
NCT04225507Not Applicable

Technology-Supported Treatment of Sleep Apnea in Prediabetes

Active Not Recruiting
NCT01136122Not Applicable

Effects of PAP Treatment of OSA in Patients With Heart Failure

Withdrawn
NCT06748703Not Applicable

Optic Nerve Injury in Obstructive Sleep Apnea Patients

Recruiting
NCT03948373Not Applicable

Normotensive OSA Patients With Dipper Circadian Blood Pressure Pattern

Recruiting
NCT06554496Not Applicable

XOR Levels in OSA Patients (XOR-OSA)

Recruiting
NCT04251975Not Applicable

Masked Hypertensive Patients With Obstructive Sleep Apnea

Completed
NCT03987425Not Applicable

Normotensive OSA Patients With Nondipper Circadian Blood Pressure Pattern

Completed
NCT04326075Not Applicable

Early CPAP in COVID-19 Patients With Respiratory Failure.

Completed
NCT02954224Not Applicable

Prevention Of Delirium in Elderly With Obstructive Sleep Apnea (PODESA)

Completed
NCT01825291

Sleep-disordered Breathing in Postmenopausal Women

Completed
NCT04407949Not Applicable

Comparison of Sleep Disordered Breathing Events Detected by the CPAP Device "prismaLine" With Polysomnography

Completed
NCT02533050Not Applicable

Attentional Capacity and Working Memory in Coronary Artery Disease Patients: Impact of the Presence of a Sleep Apnea Syndrome and Chronic Effects of Treatment With CPAP

Terminated
NCT01554527Not Applicable

Continuous Positive Airway Pressure (CPAP) After Adenotonsillectomy in Children

Completed
NCT01900379Not Applicable

PAC-IC-SAOS Obstructive Sleep Apnea Syndrome and Ventricular Function

Completed
NCT01400542

Sleep Apnea in Early to Mid-Stage Alzheimer's Disease

Terminated
NCT01505959Phase 4

Blood Pressure Reduction Induced by CPAP in Sleep Apnea Patients at High Cardiovascular Risk : OPTISAS 2 Study

Unknown
NCT00780923Not Applicable

Effect of Continuous Positive Airway Pressure Treatment on Inflammation in Patients With Obstructive Sleep Apnea

Completed
NCT01015872Not Applicable

The Roles of Prostanoids in Patients With Sleep Apnea Syndrome

Completed
NCT00942110Not Applicable

Alterations in Postprandial Glucose and Lipid Metabolism in Patients With Obstructive Sleep Apnea

Completed

Drug Details

Intervention Type
DEVICE
Total Trials
21